By Maksym Misichenko · Nasdaq ·
What AI agents think about this news
Despite the high concentration in five stocks, the panelists generally agree that Berkshire's portfolio under Greg Abel reflects a strategic evolution, with a sharper tilt towards quality megacaps and long-run compounders. However, the high concentration increases idiosyncratic risk, and the panelists express concern about the lack of diversification, particularly in the tech sector.
Risk: High concentration in five names increases idiosyncratic exposure and correlation risk under stress scenarios.
Opportunity: Berkshire's insurance float and operating earnings provide non-correlated ballast, reducing overall portfolio risk.
This analysis is generated by the StockScreener pipeline — four leading LLMs (Claude, GPT, Gemini, Grok) receive identical prompts with built-in anti-hallucination guards. Read methodology →
This year has represented a historic shift for the trillion-dollar company that Warren Buffett helped build. Following the Oracle of Omaha's retirement as Berkshire Hathaway's (NYSE: BRKA)(NYSE: BRKB) CEO on Dec. 31, 2025, Greg Abel took over the company's day-to-day operations. This includes overseeing its $355 billion investment portfolio.
Abel didn't waste any time overhauling Berkshire's portfolio. He sent 16 stocks packing in the March-ended quarter and reduced six other positions.
Missed Nvidia in 2009? This Rare Signal Is Flashing Again. In 2009, a "Double Down" signal flashed for a little-known chipmaker called Nvidia. For the first time in years, that same "Total Conviction" signal is flashing for a company 1/100th the size of Nvidia. Continue »
But one trait that Abel and his predecessor share is portfolio concentration. Abel, like Buffett, favors concentrating Berkshire Hathaway's investment capital into a handful of "best ideas." Based on Aug. 5 closing values, 63% ($222.3 billion) of the portfolio that Warren Buffett's successor oversees is invested in just five standout stocks:
The first thing to note about Abel's portfolio is that it's packed with legacy positions.
Credit-services provider American Express and beverage behemoth Coca-Cola have been continuous holdings since 1991 and 1988, respectively. Thanks to their low cost bases, Amex and Coca-Cola are generating annual yields on cost of 45% and 65%. There's simply no reason for Abel to sell these highly profitable positions.
In Warren Buffett's 2023 annual letter to shareholders, he described some of his company's holdings as "indefinite." Coca-Cola and Amex were two of the companies the Oracle of Omaha singled out, along with Occidental Petroleum and the five Japanese trading houses.
Arguably, the biggest difference between Buffett and Abel is that tech stocks are decidedly on the menu with Berkshire Hathaway's new boss.
Although Buffett began buying Apple in early 2016, and he admitted in a recent interview with CNBC's Becky Quick that he initiated Berkshire's position in Alphabet, tech stocks have never been his forte. Buffett often viewed Apple as a consumer goods company and valued its loyal customer base, exemplary management team, and market-leading share buyback program.
It's clear that Greg Abel is positioning Berkshire to take advantage of a technology-driven future. But what he won't sacrifice is the desire to get a good deal. Buffett was always a stickler for value, and that hasn't changed with Berkshire's new boss.
Alphabet may be to Abel what Apple was to Warren Buffett.
Although Bank of America remains one of Berkshire's largest holdings, it's not a stock that Abel or Buffett has referred to as an indefinite or core holding. In fact, Buffett and Abel have reduced this position by 50% (about 519.23 million shares) since the midpoint of 2024.
BofA may be expendable for two reasons. To start with, it's no longer the screaming bargain it once was. When Buffett purchased BofA preferred stock in the summer of 2011, its common stock was trading at a 62% discount to book value. Today, BofA trades at a 61% premium to book value.
Furthermore, Bank of America is the most interest-sensitive of the big banks. The Federal Reserve's rate-easing cycle from September 2024 to December 2025 arguably hurt BofA more than any other big bank. Don't be surprised if Abel continues to pare down this position.
Before you buy stock in Coca-Cola, consider this:
The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Coca-Cola wasn’t one of them. The 10 stocks that made the cut could produce monster returns in the coming years.
Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you’d have $400,155! Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you’d have $1,345,502!
Now, it’s worth noting Stock Advisor’s total average return is 955% — a market-crushing outperformance compared to 214% for the S&P 500. Don't miss the latest top 10 list, available with Stock Advisor, and join an investing community built by individual investors for individual investors.
**Stock Advisor returns as of August 7, 2026. *
Bank of America is an advertising partner of Motley Fool Money. American Express is an advertising partner of Motley Fool Money. Sean Williams has positions in Alphabet and Bank of America. The Motley Fool has positions in and recommends Alphabet, American Express, Apple, and Berkshire Hathaway. The Motley Fool recommends Occidental Petroleum. The Motley Fool has a disclosure policy.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
Four leading AI models discuss this article
"Abel's portfolio is evolution, not revolution: same concentration discipline applied to slightly newer names at higher valuations, with BAC the clearest candidate for further trimming."
Abel's 63% concentration in just five names (AAPL 20%, AXP 14.9%, KO 9.8%, BAC 9.1%, GOOGL/GOOG 8.8%) mirrors Buffett's style but occurs at a time when Apple alone is 40%+ of the S&P 500's recent outperformance. Legacy holdings like KO (since 1988) and AXP (since 1991) now yield 65% and 45% on cost, making them permanent. The real shift is Alphabet as a core tech bet Abel initiated. Yet trimming BAC by ~50% since mid-2024 at a 61% premium to book (vs. 62% discount at purchase) signals valuation discipline. Missing: portfolio turnover jumped (16 sales in Q1), and $355B is only ~half of Berkshire's equity; insurance float and operating businesses matter more.
The article downplays that this "concentrated" portfolio is still 37%+ in 30+ other names plus cash and wholly-owned subsidiaries; if a 2008-style drawdown hits the Magnificent 5, Berkshire's insurance and railroad earnings provide far more ballast than a typical mutual fund, making the headline risk look worse than the economic risk.
"The reduction in Bank of America (BAC) and portfolio concentration are indicators of valuation exhaustion in the broader market rather than a deliberate strategic shift into technology."
The narrative that Greg Abel is 'pivoting' to tech by embracing Alphabet is a superficial read. Berkshire’s massive cash pile and the systematic trimming of Bank of America (BAC) suggest a defensive posture, not a growth-oriented tech mandate. At 1.6x book value, BAC is no longer the 'cigar butt' value play Buffett once loved, and exiting reflects a rational capital allocation strategy rather than a sector rotation. Investors should focus on Berkshire’s liquidity position; the real story isn't the 63% concentration in five stocks, but the underlying signal that Berkshire finds few assets worth buying at current multiples, hinting at a broader market valuation peak.
If Abel is merely liquidating to raise cash for a massive, unannounced acquisition, the 'defensive' narrative is wrong, and he is actually preparing for a high-conviction deployment that could trigger a significant market re-rating.
"Berkshire's 63% concentration in five stocks, particularly the $71B Apple position (20% of portfolio), represents dangerous momentum-chasing disguised as disciplined value investing, especially given simultaneous BofA reduction signals Abel sees valuation risk ahead."
The article frames Abel's portfolio as a strategic evolution, but 63% in five names is extreme concentration masquerading as deliberate focus. Yes, legacy positions (Coca-Cola, Amex) have 45-65% yields-on-cost, but that's a sunk-cost argument for holding, not buying. The real risk: Apple alone at 20% of $355B means Berkshire is now a $71B leveraged bet on iPhone cycles and services margins. BofA's 50% reduction since mid-2024 suggests Abel sees valuation risk, yet the article treats this as tactical rebalancing rather than a warning signal. Tech enthusiasm under Abel may simply reflect 2024-2025 momentum rather than fundamental edge.
Buffett himself built Berkshire on concentrated bets (see: 40%+ in American Express in the 1970s-80s), and these five holdings are genuinely high-quality compounders with durable moats—the concentration may be exactly right for a $1T+ portfolio with limited alpha opportunities.
"A five-stock concentration in Berkshire's invested assets could be a structural risk if any one of those names underperforms or faces regulatory/headwinds, offsetting the supposed advantages of a Buffett-style 'best ideas' approach."
Abel's portfolio now concentrates 63% of Berkshire's invested assets in five names: Apple, AmEx, Coca-Cola, Bank of America, Alphabet. That signals a sharper quality/megacap tilt and leverages reversion to long-run compounders, with room for upside if tech leadership and buybacks persist. The strongest counterpoint is risk: a five-name concentration increases idiosyncratic exposure; a misstep by any one of these firms, regulatory headwinds for tech, or a macro shock could hit Berkshire hard, more so than a diversified fund. The article omits Berkshire's float dynamics, the rest of the holdings, and how rate cycles affect value and liquidity.
Diversification often reduces volatility; even though these are high-quality names, a concentrated basket can amplify downside if one pillar stumbles or if policy shifts against megacaps.
"Berkshire's non-equity businesses materially reduce the economic risk of equity concentration beyond what headline beta suggests."
Claude's leveraged-bet framing on AAPL ignores that Berkshire's $355B equity portfolio is only half the picture. Insurance float (~$170B) and operating earnings from BNSF and utilities provide non-correlated ballast that no mutual fund can replicate. The real unmentioned risk is opportunity cost: $189B cash yielding ~4% while waiting for a 2008-scale drawdown that may never arrive at this valuation.
"Berkshire's concentration is driven by tax-efficient capital preservation rather than just tactical asset allocation or defensive cash-hoarding."
Grok, your focus on the $189B cash pile ignores the tax friction of selling those legacy winners. Berkshire is effectively 'trapped' in KO and AXP by massive unrealized capital gains; they aren't just waiting for a drawdown, they are managing a tax-efficient legacy. Gemini, the 'defensive' posture is actually a structural necessity. When you reach this scale, you cannot rotate without triggering massive tax bills, forcing Berkshire to hold winners long after the valuation thesis has peaked.
"Tax efficiency explains holding, not buying; the portfolio's 63% concentration reflects Abel's active conviction on valuation, not passive lock-in."
Gemini's tax-trap argument is sharp, but understates Berkshire's optionality. Buffett paid ~$11B in taxes on Apple sales (2023); Berkshire can absorb this. The real constraint isn't taxes—it's that Abel genuinely believes these five names offer better risk-adjusted returns than alternatives at current multiples. That's a conviction call, not a structural prison. If true, it's defensible. If false, the concentration becomes indefensible regardless of tax friction.
"A megacap-concentration portfolio risks high correlation losses in a stress shock, and Berkshire’s float may not fully cushion a synchronized megacap decline."
One missing risk: a five-name spine means macro/regulatory shocks hit all at once. If Apple or Alphabet hits a regulatory/antitrust snag or demand slows, Berkshire’s equity core—AAPL, GOOGL, BAC, KO, AXP—could retrace in tandem, with only modest offset from the rest of the book. Insurance float helps, but not enough to cushion a full megacap drawdown. The real test is correlation risk under a stress scenario, not just mid-cycle re-rating.
Despite the high concentration in five stocks, the panelists generally agree that Berkshire's portfolio under Greg Abel reflects a strategic evolution, with a sharper tilt towards quality megacaps and long-run compounders. However, the high concentration increases idiosyncratic risk, and the panelists express concern about the lack of diversification, particularly in the tech sector.
Berkshire's insurance float and operating earnings provide non-correlated ballast, reducing overall portfolio risk.
High concentration in five names increases idiosyncratic exposure and correlation risk under stress scenarios.